664.30 -76.61 -1.53% 581.34 659.12 -77.78 -1.80% Profit from the sale of claims on accounts receivable and brand rights 18.80 - 18.80 N.A. Sharing of gain (loss) from investment value of the associate and
% 1,129.77 1,232.02 (102.24) (8.30%) Net profit attributable to owner of the parent 236.49 222.55 13.94 6.27% 1,117.52 1,221.18 (103.66) (8.49%) Earnings per share (EPS) 0.14 0.13 0.01 6.27% 0.67 0.73 (0.06
consolidated sales and services income excluding construction revenue under concession agreement of 3,075.80 million Baht, decreased by 186.46 million Baht or 5.72%) and Net profit attributable to Equity holders
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
days 66 69 72 Cash Conversion Cycle days 84 81 75 Finanial data and profitability ratios Sales revenues million baht 53,067 49,224 46,887 %change (%) 7.8% 5.0% (0.11%) Gross profit million baht 12,123
%) (43.31) 29.4% Gross Profit 126.54 46.2% 164.91 46.4% 38.37 30.3% SG&A (48.13) (17.6%) (69.08) (19.4%) (20.95) 43.5% Operating Profit 78.41 28.6% 95.83 26.9% 17.42 22.2% Share of Profit in Associates 0.15
services 59.31 64.61 (5.30) (8.20) Total Costs of Sales and Services 167.80 182.83 (15.03) (8.22) Gross Profit 57.22 65.77 (8.55) (13.00) Other incomes 1.16 5.31 (4.15) (78.15) Distribution costs 18.00 17.80
% Gain from exchange rate Other income 3.03 2.10 0.94 45% Total revenues 295.72 233.17 62.55 27% Cost of sales and services 208.23 159.63 48.60 30% Gross profit 84.46 71.44 13.01 18% Gross profit margin 29
According to referrals from the Stock Exchange of Thailand (SET) and the SEC’s further investigation, there were facts and evidence leading to believe that the actions of the three persons above
2017 compared to Q4 2016: Q4 2017 Q4 2016 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and service income 209.13 181.21 27.92 15% Gain from exchange rate 0.44 0.57 -0.13 -23% Other income